Overview

A Study of RAY1225 in Participants With Obesity

Status:
RECRUITING

Trial end date:
2025-12-20

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with Obesity. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.

Phase:

PHASE2

Details

Lead Sponsor:

Guangdong Raynovent Biotech Co., Ltd